Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples

Journal of Infectious Diseases

Volumn 205, Issue 3, 2012, Pages 358-365

  Hughes, James P ^a,c   Baeten, Jared M ^a   Lingappa, Jairam R ^a,b   Magaret, Amalia S ^a,b   Wald, Anna ^a   De Bruyn, Guy ^d   Kiarie, James ^e   Inambao, Mubiana ^f   Kilembe, William ^f   Farquhar, Carey ^a   Celum, Connie ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e KENYATTA NATIONAL HOSPITAL   (Kenya)

^f Rwanda Zambia HIV Research Group   (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; VIRUS RNA;

ADULT; ARTICLE; CIRCUMCISION; COHORT ANALYSIS; COITUS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENITAL ULCER; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RATE; INFECTION RISK; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MARITAL THERAPY; NEGRO; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SAFE SEX; SEXUAL TRANSMISSION; TRICHOMONAS VAGINALIS; UNSAFE SEX; UTERINE CERVICITIS; VAGINITIS; VIRUS TRANSMISSION;

ADULT; AFRICA; CONDOMS; FAMILY CHARACTERISTICS; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RNA, VIRAL; SEXUAL BEHAVIOR; VIRAL LOAD;

EID: 84855902980     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir747     Document Type: Article

References (20)

1. Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis 2008;8:553-63.
2. Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009;9:118-29.
3. Downs AM, De Vincenzi I. Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European Study Group in Heterosexual Transmission of HIV. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:388-95. (Pubitemid 126448572)
4. Fideli US, Allen SA, Musonda R, et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses 2001;17:901-10. (Pubitemid 32881333)
5. Saracco A, Veglia F, Lazzarin A. Risk of HIV-1 transmission in heterosexual stable and random couples. The Italian Partner Study. J Biol Regul Homeost Agents 1997;11:3-6. (Pubitemid 27503816)
6. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005;191:1403-9. (Pubitemid 40563350)
7. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001;357:1149-53. (Pubitemid 32378686)
8. Campbell MS, Mullins JI, Hughes JP, et al. Partners in Prevention HSV/HIV Study Team. Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial. PLoS One 2011;6:e16986.
9. Celum C, Wald A, Lingappa JR, et al. Partners in Prevention HSV/HIV Study Team. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010;362:427-39.
10. Lingappa JR, Baeten JM, Wald A, et al. Partners in Prevention HSV/HIV Study Team. Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 2010;375:824-33.
11. Lingappa JR, Kahle E, Mugo N, et al. Partners HSV-2/HIV-1 Transmission Study Team. Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the Partners Study. PLoS One 2009;4:e5272.
12. Jewell NP, Shiboski SC. Statistical analysis of HIV infectivity based on partner studies. Biometrics 1990;46:1133-50.
13. StataCorp. Stata: release 11. Statistical software. College Station, TX: StatCorp LP, 2009.
14. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002;1. CD003255.
15. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002;185:45-52. (Pubitemid 34043015)
16. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006;20:73-83. (Pubitemid 41818117)
17. Donnell D, Baeten JM, Kiarie J, et al. Partners in Prevention HSV/HIV Transmission Study Team. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010;375:2092-8.
18. Cohen MS, Chen YQ, McCauley M, et al. HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med 2011;365:493-505.
19. Barnabas RV, Webb EL, Weiss HA, Wasserheit JN. The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis. AIDS 2011;25:1559-73.
20. Modjarrad K, Vermund SH. An addition to the effect of treating coinfections on HIV-1 viral load. Lancet Infect Dis 2011;11:81.